Jon Pritchard

16.7k total citations · 3 hit papers
180 papers, 11.7k citations indexed

About

Jon Pritchard is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Jon Pritchard has authored 180 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 46 papers in Physiology and 43 papers in Oncology. Recurrent topics in Jon Pritchard's work include Histiocytic Disorders and Treatments (44 papers), Neuroblastoma Research and Treatments (38 papers) and Renal and related cancers (32 papers). Jon Pritchard is often cited by papers focused on Histiocytic Disorders and Treatments (44 papers), Neuroblastoma Research and Treatments (38 papers) and Renal and related cancers (32 papers). Jon Pritchard collaborates with scholars based in United Kingdom, Canada and United States. Jon Pritchard's co-authors include Frank Berthold, Victoria Castel, F Hedborg, M Favrot, Valerie Broadbent, Niels Carlsen, Bruno De Bernardi, Audrey E. Evans, G M Brodeur and Penelope Brock and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Jon Pritchard

175 papers receiving 11.3k citations

Hit Papers

Revisions of the internat... 1986 2026 1999 2012 1993 1986 1997 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
    1993 1.7k citations Jon Pritchard et al. Journal of Clinical Oncology profile →
  2. The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity
    1986 903 citations Jon Pritchard et al. profile →
  3. Contemporary classification of histiocytic disorders
    1997 597 citations R. Maarten Egeler, Helmut Gadner et al. Medical and Pediatric Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jon Pritchard 3.8k 3.7k 2.9k 2.4k 2.4k 180 11.7k
D. Harms 2.7k 0.7× 1.5k 0.4× 3.0k 1.0× 1.6k 0.7× 492 0.2× 235 8.6k
Harry P. Kozakewich 1.6k 0.4× 2.1k 0.6× 6.1k 2.1× 2.7k 1.1× 1.1k 0.5× 183 10.4k
Katsuyuki Aozasa 3.3k 0.9× 980 0.3× 1.6k 0.5× 4.7k 1.9× 565 0.2× 311 11.4k
Giulio J. D’Angio 6.0k 1.6× 3.8k 1.0× 2.1k 0.7× 1.7k 0.7× 702 0.3× 279 13.1k
Andrew M. Davidoff 6.5k 1.7× 1.7k 0.4× 2.3k 0.8× 4.2k 1.7× 262 0.1× 368 13.6k
Laurence Brugières 2.9k 0.8× 2.1k 0.6× 1.4k 0.5× 3.1k 1.3× 286 0.1× 239 9.7k
Marco Chilosi 2.8k 0.7× 775 0.2× 1.1k 0.4× 3.5k 1.4× 1.7k 0.7× 292 12.9k
Gilles Thomas 6.5k 1.7× 2.0k 0.5× 1.8k 0.6× 4.1k 1.7× 549 0.2× 248 16.1k
Paul S. Thorner 3.5k 0.9× 1.8k 0.5× 1.6k 0.5× 1.9k 0.8× 380 0.2× 321 9.1k
Peter G. Isaacson 1.3k 0.3× 1.2k 0.3× 2.8k 0.9× 4.9k 2.0× 1.1k 0.4× 132 12.8k

Countries citing papers authored by Jon Pritchard

Since Specialization
Citations

This map shows the geographic impact of Jon Pritchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Pritchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Pritchard more than expected).

Fields of papers citing papers by Jon Pritchard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Pritchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Pritchard. The network helps show where Jon Pritchard may publish in the future.

Co-authorship network of co-authors of Jon Pritchard

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Pritchard. A scholar is included among the top collaborators of Jon Pritchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Pritchard. Jon Pritchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Keith, et al.. (2024). Docking and structure activity relationship studies of potent and selective thiazolidinethione GSK-3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 117. 130074–130074.
2.
Beverley, Peter C. L., R. Maarten Egeler, R.J. Arceci, & Jon Pritchard. (2005). The Nikolas Symposia and histiocytosis. Nature reviews. Cancer. 5(6). 488–494. 37 indexed citations
3.
4.
Mitchell, Christopher, P. Morris Jones, Anna Kelsey, et al.. (2000). The treatment of Wilms' tumour: results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study. British Journal of Cancer. 83(5). 602–608. 90 indexed citations
5.
Kiely, Edward M., et al.. (2000). Pelvic neuroblastoma: Low mortality and high morbidity. Journal of Pediatric Surgery. 35(5). 724–728. 30 indexed citations
6.
Munn, S.E., et al.. (1999). Use of indomethacin in Langerhans cell histiocytosis. Medical and Pediatric Oncology. 32(4). 247–249. 2 indexed citations
7.
Munn, S.E., et al.. (1999). Use of indomethacin in Langerhans cell histiocytosis. Medical and Pediatric Oncology. 32(4). 247–249. 12 indexed citations
8.
Munn, S.E., et al.. (1999). Use of indomethacin in Langerhans cell histiocytosis. Medical and Pediatric Oncology. 32(4). 247–249. 46 indexed citations
9.
10.
Brock, Pamela, et al.. (1991). Bloom syndrome and haematological malignancy in three children. Medical and Pediatric Oncology. 19. 362. 4 indexed citations
11.
Brock, Penelope, Jon Pritchard, S. Bellman, & CR Pinkerton. (1988). Ototoxicity of high‐dose cis‐platinum in children. Medical and Pediatric Oncology. 16(5). 368–369. 33 indexed citations
12.
Pritchard, Jon, et al.. (1987). IS HIGH-DOSE MELPHALAN (HDM) OF VALUE IN TREATMENT OF ADVANCED NEUROBLASTOMA (AN) - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL BY THE EUROPEAN NEUROBLASTOMA STUDY-GROUP (ENSG). British Journal of Cancer. 55. 341–341. 15 indexed citations
13.
Kraker, Jan de, Jon Pritchard, Oliver Hartmann, & J. Ninane. (1987). Single-Agent Ifosfamide in Patients with Recurrent Neuroblastoma (Ensg Study 2). Pediatric Hematology and Oncology. 4(2). 101–104. 10 indexed citations
14.
Sacks, Steven H., et al.. (1986). Chronic dermal sinuses as a manifestation of histiocytosis X.. BMJ. 292(6528). 1097–1098. 6 indexed citations
15.
Womer, Richard B., Jon Pritchard, & T M Barratt. (1985). Renal toxicity of cisplatin in children. The Journal of Pediatrics. 106(4). 659–663. 79 indexed citations
16.
Vivian, G., et al.. (1984). Immunolocalization of neuroblastoma using radiolabeled monoclonal antibody UJ13A. The Journal of Pediatrics. 105(2). 252–256. 44 indexed citations
17.
Pritchard, Jon, T J McElwain, & John Graham‐Pole. (1982). High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. British Journal of Cancer. 45(1). 86–94. 126 indexed citations
18.
Kemshead, J T, Melvyn F. Greaves, Jon Pritchard, et al.. (1981). Mono clonal antibodies to human neuro blastoma cells. British Journal of Cancer. 43(4). 568. 1 indexed citations
19.
Punt, Jonathan, Jon Pritchard, J. R. Pincott, & Kenneth Till. (1980). Neuroblastoma: A review of 21 cases presenting with spinal cord compression. Cancer. 45(12). 3095–3101. 61 indexed citations
20.
Pritchard, Jon, et al.. (1978). Ultrasonography of the testis--correlation with radiotracer perfusion.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 19(6). 615–18. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Harms Breakdown of academic impact, for papers by Harry P. Kozakewich Breakdown of academic impact, for papers by Katsuyuki Aozasa Breakdown of academic impact, for papers by Giulio J. D’Angio Breakdown of academic impact, for papers by Andrew M. Davidoff Breakdown of academic impact, for papers by Laurence Brugières Breakdown of academic impact, for papers by Marco Chilosi Breakdown of academic impact, for papers by Gilles Thomas Breakdown of academic impact, for papers by Paul S. Thorner Breakdown of academic impact, for papers by Peter G. Isaacson
Rankless by CCL
2026